These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38570779)

  • 21. Persistence of oral pre-exposure prophylaxis (PrEP) among adolescent girls and young women initiating PrEP for HIV prevention in Kenya.
    de Dieu Tapsoba J; Zangeneh SZ; Appelmans E; Pasalar S; Mori K; Peng L; Tao J; Drain P; Okomo G; Bii S; Mukabi J; Zobrist S; Brady M; Obanda R; Madiang DO; Cover J; Duerr A; Chen YQ; Obong'o C
    AIDS Care; 2021 Jun; 33(6):712-720. PubMed ID: 32951437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.
    Ongolly FK; Dolla A; Ngure K; Irungu EM; Odoyo J; Wamoni E; Peebles K; Mugwanya K; Mugo NR; Bukusi EA; Morton J; Baeten JM; O'Malley G
    J Acquir Immune Defic Syndr; 2021 May; 87(1):e150-e158. PubMed ID: 33492024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR; Yotebieng K; Otticha S; Rota G; Agot K; Ohaga S; Syvertsen JL
    J Int AIDS Soc; 2019 Apr; 22(4):e25266. PubMed ID: 30983147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gay, bisexual, and queer men's confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over time.
    Grace D; Daroya E; Gaspar M; Wells A; Hull M; Lachowsky N; Tan DHS
    Sex Health; 2023 Jul; 20(3):223-231. PubMed ID: 37257867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal shifts in HIV-related risk factors among cohorts of adolescent girls and young women enrolled in DREAMS programming: evidence from Kenya, Malawi and Zambia.
    Mathur S; Heck CJ; Kishor Patel S; Okal J; Chipeta E; Mwapasa V; Chimwaza W; Musheke M; Mahapatra B; Pulerwitz J; Pilgrim N
    BMJ Open; 2022 Feb; 12(2):e047843. PubMed ID: 35105561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa.
    Smith PJ; Daniels J; Bekker LG; Medina-Marino A
    BMC Public Health; 2023 Mar; 23(1):418. PubMed ID: 36864381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
    Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
    Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Kenya.
    Karuga RN; Njenga SN; Mulwa R; Kilonzo N; Bahati P; O'reilley K; Gelmon L; Mbaabu S; Wachihi C; Githuka G; Kiragu M
    PLoS One; 2016; 11(4):e0151716. PubMed ID: 27073896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study.
    Ntinga X; Isehunwa OO; Msimango LI; Smith PM; Matthews LT; Van Heerden A
    BMC Public Health; 2024 Feb; 24(1):553. PubMed ID: 38389039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP.
    Jongen VW; Hoornenborg E; van den Elshout MA; Boyd A; Zimmermann HM; Coyer L; Davidovich U; Anderson PL; de Vries HJ; Prins M; Schim van der Loeff MF;
    J Int AIDS Soc; 2021 May; 24(5):e25708. PubMed ID: 33973373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PrEP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya.
    Kimani M; van der Elst EM; Chiro O; Oduor C; Wahome E; Kazungu W; Shally M; Rinke de Wit TF; Graham SM; Operario D; Sanders EJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25323. PubMed ID: 31194291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda.
    Stalter R; Mugwanya K; Thomas K; Donnell D; Mujugira A; Ngure K; Celum C; Kidoguchi L; Bukusi E; Baeten J; Heffron R;
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):174-181. PubMed ID: 32658130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
    Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
    AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.